CHARLES RIVER LAB (CRL)

Healthcare: Biotechnology

Brokerage Ratings
Closing price on 12/31/2009: $33.69
Filers holding this stock on 12/31/2009: 229
Aggregate shares on 12/31/2009: 65,180,095
Aggregate shares on 09/30/2009: 63,582,858
Percent change: 2.512056%
View insider trading info since Jan. 1 2008
Quarter 1: Quarter 2:
Brokerage Ratings on this stock:
Positive:
3
Neutral:
6
Negative:
1
Brokerage Date Issued Rating Price Target
DEUTSCHE BANK 01/07/2010 BUY $39.00
BARCLAYS CAPITAL 11/09/2009 EQUAL WEIGHT
DEUTSCHE SECURITIES 05/13/2009 HOLD
JEFFERIES & CO 04/20/2009 HOLD $33.00
UBS 02/01/2009 SELL
LEHMAN BROTHERS 08/06/2008 OVERWEIGHT $78.00
WACHOVIA 11/28/2007 MKT PERFORM
COWEN & CO 07/15/2007 NEUTRAL
BANC OF AMERICA SEC 06/28/2007 NEUTRAL
ROBERT W. BAIRD 05/02/2007 OUTPERFORM $54.00
Non-derivative Insider Transactions
Transaction Date Owner Shares Purchased/Sold Edgar filing
08/11/2008
ACKERMAN THOMAS F
 0 View Filing
08/11/2008
GILLETT NANCY
 0 View Filing
08/14/2008
ACKERMAN THOMAS F
 0 View Filing
08/26/2008
CHUBB STEPHEN D
 0 View Filing
09/22/2008
FOSTER JAMES C
 0 View Filing
09/22/2008
FOSTER JAMES C
 0 View Filing
09/22/2008
FOSTER JAMES C
 0 View Filing
10/01/2008
THIER SAMUEL O MD
 0 View Filing
10/01/2008
CHUBB STEPHEN D
 0 View Filing
05/12/2009
MASSARO GEORGE
 0 View Filing
05/29/2009
GILLETT NANCY
 0 View Filing
08/11/2009
KOCHEVAR DEBORAH TURNER
 0 View Filing
08/12/2009
GILLETT NANCY
 0 View Filing
08/21/2009
JOHST DAVID P
 0 View Filing
10/01/2009
CHUBB STEPHEN D
 0 View Filing